These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interplay between PREX2 mutations and the PI3K pathway and its effect on epigenetic regulation of gene expression in NRAS-mutant melanoma. Lissanu Deribe Y Small GTPases; 2016 Jul; 7(3):178-85. PubMed ID: 27111337 [TBL] [Abstract][Full Text] [Related]
6. PREX2, a new breed of cancer gene with too many spots? Mense S; Hodakoski C; Parsons R Pigment Cell Melanoma Res; 2012 Jul; 25(4):409-10. PubMed ID: 22578146 [No Abstract] [Full Text] [Related]
7. Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth. Barsotti AM; Ryskin M; Zhong W; Zhang WG; Giannakou A; Loreth C; Diesl V; Follettie M; Golas J; Lee M; Nichols T; Fan C; Li G; Dann S; Fantin VR; Arndt K; Verhelle D; Rollins RA Oncotarget; 2015 Feb; 6(5):2928-38. PubMed ID: 25671303 [TBL] [Abstract][Full Text] [Related]
8. RIP1 Kinase Is an Oncogenic Driver in Melanoma. Liu XY; Lai F; Yan XG; Jiang CC; Guo ST; Wang CY; Croft A; Tseng HY; Wilmott JS; Scolyer RA; Jin L; Zhang XD Cancer Res; 2015 Apr; 75(8):1736-48. PubMed ID: 25724678 [TBL] [Abstract][Full Text] [Related]
9. PTEN inhibits PREX2-catalyzed activation of RAC1 to restrain tumor cell invasion. Mense SM; Barrows D; Hodakoski C; Steinbach N; Schoenfeld D; Su W; Hopkins BD; Su T; Fine B; Hibshoosh H; Parsons R Sci Signal; 2015 Mar; 8(370):ra32. PubMed ID: 25829446 [TBL] [Abstract][Full Text] [Related]
10. P-Rex1 and P-Rex2 RacGEFs and cancer. Srijakotre N; Man J; Ooms LM; Lucato CM; Ellisdon AM; Mitchell CA Biochem Soc Trans; 2017 Aug; 45(4):963-77. PubMed ID: 28710285 [TBL] [Abstract][Full Text] [Related]
11. Identification of ARHGEF17, DENND2D, FGFR3, and RB1 mutations in melanoma by inhibition of nonsense-mediated mRNA decay. Bloethner S; Mould A; Stark M; Hayward NK Genes Chromosomes Cancer; 2008 Dec; 47(12):1076-85. PubMed ID: 18677770 [TBL] [Abstract][Full Text] [Related]
12. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells. Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of Bmi-1 suppresses epithelial‑mesenchymal transition in melanoma. Liu Y; Chu Z; Li Q; Peng B; Xu S; Lian CG; Geng S Oncol Rep; 2017 Jan; 37(1):139-146. PubMed ID: 27878257 [TBL] [Abstract][Full Text] [Related]
14. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells. Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma. Zhao Y; Zhang B; Lei Y; Sun J; Zhang Y; Yang S; Zhang X Tumour Biol; 2016 Oct; 37(10):13167-13176. PubMed ID: 27456357 [TBL] [Abstract][Full Text] [Related]
16. Extract of Cordyceps militaris inhibits angiogenesis and suppresses tumor growth of human malignant melanoma cells. Ruma IM; Putranto EW; Kondo E; Watanabe R; Saito K; Inoue Y; Yamamoto K; Nakata S; Kaihata M; Murata H; Sakaguchi M Int J Oncol; 2014 Jul; 45(1):209-18. PubMed ID: 24789042 [TBL] [Abstract][Full Text] [Related]
17. Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden. Schramm SJ; Li SS; Jayaswal V; Fung DC; Campain AE; Pang CN; Scolyer RA; Yang YH; Mann GJ; Wilkins MR Pigment Cell Melanoma Res; 2013 Sep; 26(5):708-22. PubMed ID: 23738911 [TBL] [Abstract][Full Text] [Related]
18. Antitumor agent 25-epi Ritterostatin GN1N induces endoplasmic reticulum stress and autophagy mediated cell death in melanoma cells. Riaz Ahmed KB; Kanduluru AK; Feng L; Fuchs PL; Huang P Int J Oncol; 2017 May; 50(5):1482-1490. PubMed ID: 28393217 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression. Bai J; Zhang Z; Li X; Liu H Cancer Biomark; 2015; 15(5):599-608. PubMed ID: 26406949 [TBL] [Abstract][Full Text] [Related]
20. Selumetinib Inhibits Melanoma Metastasis to Mouse Liver Ryu SH; Heo SH; Park EY; Choi KC; Ryu JW; Lee SH; Lee SW Anticancer Res; 2017 Feb; 37(2):607-614. PubMed ID: 28179307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]